NO20024988L - Formulering som har mobiliserende aktivitet - Google Patents

Formulering som har mobiliserende aktivitet

Info

Publication number
NO20024988L
NO20024988L NO20024988A NO20024988A NO20024988L NO 20024988 L NO20024988 L NO 20024988L NO 20024988 A NO20024988 A NO 20024988A NO 20024988 A NO20024988 A NO 20024988A NO 20024988 L NO20024988 L NO 20024988L
Authority
NO
Norway
Prior art keywords
formulation
mobilizing activity
haematopoietic
mobilizing
activity
Prior art date
Application number
NO20024988A
Other languages
English (en)
Norwegian (no)
Other versions
NO20024988D0 (no
Inventor
Laura Ferro
Roberto Porta
Massimo Iacobelli
Alessandro Massimo Gianni
Carmelo Carlo Stella
Original Assignee
Gentium Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gentium Spa filed Critical Gentium Spa
Publication of NO20024988D0 publication Critical patent/NO20024988D0/no
Publication of NO20024988L publication Critical patent/NO20024988L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/193—Colony stimulating factors [CSF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO20024988A 2000-04-18 2002-10-16 Formulering som har mobiliserende aktivitet NO20024988L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00830293A EP1147777A1 (en) 2000-04-18 2000-04-18 Combination of defibrotide and G-CSF and its use to activate haematopoietic progenitors
PCT/EP2001/004105 WO2001078761A2 (en) 2000-04-18 2001-04-10 Mixture of defibrotide and g-csf ant its use for activating haematopoietic progenitors

Publications (2)

Publication Number Publication Date
NO20024988D0 NO20024988D0 (no) 2002-10-16
NO20024988L true NO20024988L (no) 2002-12-02

Family

ID=8175292

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20024988A NO20024988L (no) 2000-04-18 2002-10-16 Formulering som har mobiliserende aktivitet

Country Status (31)

Country Link
US (1) US20040131588A1 (is)
EP (3) EP1147777A1 (is)
JP (1) JP5205668B2 (is)
KR (1) KR100849491B1 (is)
CN (1) CN1183962C (is)
AT (2) ATE443524T1 (is)
AU (2) AU5832201A (is)
BG (1) BG107203A (is)
CA (1) CA2406179C (is)
CY (1) CY1104971T1 (is)
CZ (1) CZ20023426A3 (is)
DE (2) DE60140015D1 (is)
DK (2) DK1621207T3 (is)
EE (1) EE200200596A (is)
ES (2) ES2252227T3 (is)
HR (1) HRP20020835A2 (is)
HU (1) HUP0300560A3 (is)
IL (1) IL152328A (is)
IS (1) IS2171B (is)
MX (1) MXPA02010346A (is)
NO (1) NO20024988L (is)
NZ (1) NZ522016A (is)
PL (1) PL358100A1 (is)
PT (1) PT1621207E (is)
RO (1) RO121006B1 (is)
RU (1) RU2248216C2 (is)
SI (1) SI21079B (is)
SK (1) SK14892002A3 (is)
UA (1) UA73566C2 (is)
WO (1) WO2001078761A2 (is)
ZA (1) ZA200208413B (is)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8771663B2 (en) 2000-04-18 2014-07-08 Gentium Spa Formulation having mobilising activity
US7417026B2 (en) 2003-08-13 2008-08-26 Children's Hospital Medical Center Mobilization of hematopoietic cells
JP2007535479A (ja) 2003-08-13 2007-12-06 チルドレンズ ホスピタル メディカル センター ＧＴＰａｓｅを調節するためのキメラペプチド
EP2103689A1 (en) * 2008-03-19 2009-09-23 Gentium S.p.A. Synthetic phosphodiester oligonucleotides and therapeutical uses thereof
RU2376985C1 (ru) * 2008-07-17 2009-12-27 Владислав Николаевич Ласкавый Средство для активации стволовых клеток
DK2637672T3 (en) 2010-11-12 2018-10-22 Gentium S R L DEFIBROTID FOR USE IN PROPHYLAXY AND / OR TREATMENT OF GRAPHIC VERSUS HOST DISEASE (GVHD)
MX352085B (es) 2012-06-22 2017-11-08 Gentium S R L Método a base de euglobulina para determinar la actividad biológica de defibrótido.
EP3026122A1 (en) 2014-11-27 2016-06-01 Gentium S.p.A. Cellular-based method for determining the potency of defibrotide
CN106567694A (zh) * 2016-11-14 2017-04-19 北京国泰通源技术有限公司 智能控水短节
CA3055174C (en) * 2018-01-12 2021-05-18 Cellmig Biolabs Inc. Methods for generation of cytocapsulae and cytocapsular tubes
WO2021095881A1 (ja) 2019-11-13 2021-05-20 富士フイルム株式会社 加飾フィルム、成型物、及び電子デバイス

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2154279A1 (de) * 1970-11-03 1972-05-25 Crinos Industria Farmaco Medikamente für das fibrinolytische System
IT1043823B (it) * 1970-11-03 1980-02-29 Prephar Procedimento per l estrazione di acidi nucleici da organi animali
US3899481A (en) 1970-11-03 1975-08-12 Crinos Industria Farmaco Process for the controlled partial degradation of deoxyribonucleic acid extracted from animal organs
IT1206341B (it) 1984-02-16 1989-04-14 Crinos Industria Farmaco Composizione farmaceutica per il trattamento dell'ischemia acuta del miocardio.
US4694134A (en) 1985-05-28 1987-09-15 Ajax Magnethermic Corporation Apparatus for overheating edges of skelp for the production of compression welded pipe
US5223609A (en) 1986-04-17 1993-06-29 Crinos Industria Farmacobiologica S.P.A. Process for obtaining chemically defined and reproducible polydeoxyribonucleotides
IT1190313B (it) 1986-04-17 1988-02-16 Crinos Industria Farmaco Procedimento per l'ottenimento di polidesossiribonucleotidi chimicamente definiti e riproducibili e prodotto farmacologicamente attivo risultante
IT1223322B (it) * 1987-10-23 1990-09-19 Crinos Industria Farmaco Metodo per prevenire la formazione di coaguli sanguigni nel circuito extracorporeo di apparecchi di dialisi a composizione utile per esso
JP2907447B2 (ja) * 1988-08-24 1999-06-21 中外製薬株式会社 抗血栓剤
IT1231509B (it) * 1989-09-07 1991-12-07 Crinos Industria Farmaco Composizione farmceutica ad uso topico per la terapia della fragilita' capillare.
US5199942A (en) * 1991-06-07 1993-04-06 Immunex Corporation Method for improving autologous transplantation
US5977083A (en) * 1991-08-21 1999-11-02 Burcoglu; Arsinur Method for using polynucleotides, oligonucleotides and derivatives thereof to treat various disease states
JP3021906B2 (ja) * 1992-01-28 2000-03-15 松下電器産業株式会社 電動調理機
JPH08127539A (ja) * 1994-10-31 1996-05-21 Ajinomoto Co Inc ヒトｉｌ−１１を含有する末梢血幹細胞増加剤
US5856444A (en) * 1994-11-30 1999-01-05 Chugai Seiyaku Kabushiki Kaisha Thrombocytopoiesis stimulating factor
DE69733694T2 (de) * 1996-07-10 2006-07-06 Muramatsu, Takashi, Nagoya Verwendung von proteinen aus der mk familie als hämatopoietischer faktor
AU1705599A (en) * 1997-11-26 1999-06-15 Allegheny University Of The Health Sciences Methods for mobilizing hematopoietic facilitating cells and hematopoietic stem cells into the peripheral blood
US6573372B2 (en) * 1999-01-07 2003-06-03 Heska Corporation Feline immunoglobulin E molecules and compositions there of

Also Published As

Publication number Publication date
AU2001258322B2 (en) 2006-03-16
EP1276497A2 (en) 2003-01-22
ATE443524T1 (de) 2009-10-15
ES2335776T3 (es) 2010-04-05
EP1276497B1 (en) 2005-11-23
HUP0300560A3 (en) 2005-07-28
ATE310532T1 (de) 2005-12-15
SI21079B (sl) 2006-08-31
UA73566C2 (en) 2005-08-15
AU5832201A (en) 2001-10-30
ZA200208413B (en) 2003-10-17
IL152328A (en) 2009-12-24
IS2171B (is) 2006-11-15
KR100849491B1 (ko) 2008-07-31
SI21079A (sl) 2003-06-30
CZ20023426A3 (cs) 2003-05-14
CY1104971T1 (el) 2010-03-03
RU2002130719A (ru) 2004-03-27
IS6581A (is) 2002-10-14
HRP20020835A2 (en) 2005-10-31
DK1276497T3 (da) 2006-03-27
EP1621207A3 (en) 2006-11-22
EP1621207B1 (en) 2009-09-23
DE60115222T2 (de) 2006-08-10
DE60115222D1 (de) 2005-12-29
WO2001078761A3 (en) 2002-01-24
CA2406179A1 (en) 2001-10-25
ES2252227T3 (es) 2006-05-16
DE60140015D1 (de) 2009-11-05
PL358100A1 (en) 2004-08-09
WO2001078761A2 (en) 2001-10-25
EE200200596A (et) 2004-04-15
MXPA02010346A (es) 2004-09-06
EP1621207A2 (en) 2006-02-01
KR20030010603A (ko) 2003-02-05
JP5205668B2 (ja) 2013-06-05
CN1434719A (zh) 2003-08-06
EP1147777A1 (en) 2001-10-24
BG107203A (bg) 2003-05-30
NZ522016A (en) 2004-10-29
CA2406179C (en) 2012-03-27
HUP0300560A2 (hu) 2003-06-28
RU2248216C2 (ru) 2005-03-20
US20040131588A1 (en) 2004-07-08
IL152328A0 (en) 2003-05-29
DK1621207T3 (da) 2010-02-01
SK14892002A3 (sk) 2003-06-03
JP2004500437A (ja) 2004-01-08
CN1183962C (zh) 2005-01-12
NO20024988D0 (no) 2002-10-16
PT1621207E (pt) 2009-12-28
RO121006B1 (ro) 2006-11-30

Similar Documents

Publication Publication Date Title
NO20024988L (no) Formulering som har mobiliserende aktivitet
DE60016670D1 (de) Kosmetisches Mittel enthaltend mindestens einen Hydroxystilben und Ascorbinsäure
NO20061095L (no) Vertscelle som fremstiller chimerisk anti-CD2o-antistoff samt anvendelse derav ved fremstilling av medikamenter til behandling av lidelser som involverer B-celler
DE60143477D1 (de) Verminderung der nebenwirkungen bei der oxybutynin-therapie
DK0774005T3 (da) Overfladeudtrykkelse af enzymer i genorienteret prodrug-terapi
DE69932248D1 (de) Entzündungshemmende ascorbinsäurederivate
DK261490D0 (da) New pharmaceutical compound
AU2001269688A1 (en) Combination containing an antifolate and methylmalonic acid lowering agent
IT1264530B (it) Impiego dei polisaccaridi nelle neuropatie atrofico degenerative
IL158155A0 (en) Use of erythropoietin to ameliorate chemotherapy-induced toxicity in vivo
WO2001089536A3 (en) Apoptotic entities for use in treatment of t-cell-mediated and inflammatory disorders
AU2002332488A8 (en) R-bambuterol, its preparation and therapeutic uses
YU79802A (sh) Formulacija sa aktivnošću mobilizacije
SE0000303D0 (sv) Novel compounds
NO20030988L (no) Anvendelse av en sammensetning omfattende et pollenekstrakt for behandlingav hormonrelaterte forstyrrelser
TR200302008T4 (tr) Dış retina bozukluklarının tedavisine yönelik bir ilaç üretiminde beta-adrenoseptör antagonistlerin kullanımı.
张建慧 My Bracelet
DE69829982D1 (de) Mittel und therapieverfahren für auf igf-i ansprechende erkrankungen
ES2165788B1 (es) Empleo de la levadura de cerveza en la elaboracion de un medicamento para el tratamiento del sindrome x fragil.
IT7827270A0 (it) Corpo di distribuzione ad ugello coassiale, in particolare per siringhe dentali combinate.
UY24121A1 (es) Nuevas sulfonamidas

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application